Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Faron as an Investment | Company Night Dec. 13, 2022

By Inderes
Faron Pharmaceuticals

Markku Jalkanen, CEO, talks about Faron as an investment.

Health Technology & Pharmaceutical Developer Night:
Keynote – Antti Siltanen, Inderes (link)
Faron – Markku Jalkanen, CEO (link)
Aiforia – Jukka Tapaninen, CEO (link)
Optomed – Seppo Kopsala, CEO (link)
Herantis Pharma – Antti Vuolanto, CEO (link)
BBS – Ilkka Kangasniemi, CEO (link)
Bioretec – Timo Lehtonen, CEO (link)

Health Technology & Pharmaceutical Developer Night on inderesTV (link)

Stay up to date
Company presentations

Recent videos

Talenom - Planned demerger and strategies of Talenom and Easor
18.12.2025, 11.00 Talenom
HCA Morgenbørs 18/12 - Vi ser ind i en flad europæiske åbning trods markante US fald, vi undgår igen tech-nedturen
18.12.2025, 09.55 ISS
Flügger - Q2 2025/26 Analytiker video
18.12.2025, 09.46 Flügger Group
Investing in the life science sector
18.12.2025, 07.47
HCA Morgenbørs 17/12 - Vi ser ind i lidt afventende markeder ovenpå en noget svag jobmarkedsrapport
17.12.2025, 09.21 Roblon
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.